• Parker-Hannifin recently reported fourth-quarter 2026 results showing sales rising to US$5,755 million and net income reaching US$1,091 million, alongside full-year sales of US$21.50 billion and net income of US$3.65 billion, and issued fiscal 2027 guidance calling for reported sales growth of 5.5% to 8.5% and EPS of US$30.00 to US$31.00.
• The company also closed its acquisition of Filtration Group Corporation and highlighted higher long-term margin ambitions, underlining a push toward larger-scale, higher-value filtration and aftermarket businesses.
• We’ll now examine how this combination of upbeat EPS guidance and the Filtration Group acquisition could reshape Parker-Hannifin’s investment narrative.

AI is about to change healthcare. These 44 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Parker-Hannifin Investment Narrative Recap

To own Parker-Hannifin, you need confidence in its ability to keep converting a diversified motion and control portfolio into resilient earnings, even as industrial markets evolve. The latest FY 2026 results and FY 2027 EPS guidance reinforce earnings momentum as a near term catalyst, while the biggest risk remains that acquisitions and higher debt fail to translate into sustained margin and cash flow strength. The Filtration Group deal is important here, but it does not eliminate that execution risk.

The most relevant development is the Filtration Group acquisition, which materially expands Parker-Hannifin’s filtration technologies and aftermarket footprint. This ties directly into management’s higher long term margin ambition and shift toward higher value, recurring revenue streams, potentially supporting the current premium P/E multiple. At the same time, adding another sizeable acquisition into an already active M&A playbook raises integration and cost synergy risks that sit alongside the upbeat FY 2027 sales and EPS guidance.

Yet behind the upbeat EPS guidance, investors should still be aware of how acquisition risks and high valuation could interact if...

Parker-Hannifin's narrative projects $25.1 billion revenue and $4.6 billion earnings by 2029. This requires 6.1% yearly revenue growth and about a $1.1 billion earnings increase from $3.5 billion today.

Uncover how Parker-Hannifin's forecasts yield a $1032 fair value, a 3% downside to its current price.

Exploring Other Perspectives

Some of the most pessimistic analysts, who were assuming revenue of about US$24.5 billion and earnings of roughly US$4.4 billion by 2029, see the same earnings guidance and Filtration Group acquisition very differently from you, highlighting how views can diverge sharply and why it is worth exploring several alternative scenarios before deciding how comfortable you are with Parker-Hannifin’s...

Explore 5 other fair value estimates on Parker-Hannifin - why the stock might be worth as much as 28% more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Parker-Hannifin research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Parker-Hannifin research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Parker-Hannifin's overall financial health at a glance.

Contemplating Other Strategies?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• We've uncovered the 11 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.